Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc.) for the reporting period of January 9, 2014. The filing addresses the closing of a recently disclosed registered direct offering.
Key Financial Metrics
- Capital Raised: $20 million from the registered direct offering.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide specific values for these operational or balance sheet metrics.
Material Changes
The primary material change reported is the successful closing of the $20 million registered direct offering on January 9, 2014. No other financial changes or comparisons to prior periods are detailed in this specific report.
Guidance, Outlook, and Risks
The filing references a press release (Exhibit 99.01) for further details but does not contain specific management commentary, future guidance, risk factors, or contingencies within the body of this text.
Investor Verification Checklist
- Verify the final use of proceeds from the $20 million offering.
- Review the attached press release (Exhibit 99.01) for details on the offering terms and pricing.
- Confirm the updated share count and dilution impact resulting from this transaction.
- Note the discrepancy between the requested company name (Palisade Bio) and the actual registrant (Neuralstem, Inc.).